SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States
11 references·4 citing·39 second hop
Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States (2012)Vortioxetine (Lu AA21004) 5 mg in general…Evidence-based pharmacological treatment of generalized anxiety disorder (2011)Evidence-based pharmacologica…Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR ) (2010)Diagnostic and Statistical Ma…Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale (2008)Assessing treatment effects i…Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA’s Pediatric Suicidal Risk Analysis of Antidepressants (2007)Columbia Classification Algor…An effect-size analysis of pharmacologic treatments for generalized anxiety disorder (2007)An effect-size analysis of ph…The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)The Mini-International Neurop…The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)The MOS 36-ltem Short-Form He…The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-item short-form he…The Hospital Anxiety and Depression Scale (1983)The Hospital Anxiety and Depr…A New Depression Scale Designed to be Sensitive to Change (1979)A New Depression Scale Design…THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)THE ASSESSMENT OF ANXIETY STA…Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials (2020)Comparative Remission Rates a…Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis (2019)Pharmacological and psycholog…Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis (2019)Comparative efficacy and acce…A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder (2013)A randomised, double-blind, p…Diagnostic and Statistical Manual of Mental Disorders (1988)Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) (2000)Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 (2012)Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 (2013)Diagnostic and Statistical Manual of Mental Disorders (2013)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey (1994)Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents (2001)Pharmacotherapy of anxiety disorders: a critical review (2011)Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials (2019)A RATING SCALE FOR DEPRESSION (1960)Development of a Rating Scale for Primary Depressive Illness (1967)Diagnostic Criteria for Use in Psychiatric Research (1972)The PHQ-9 (2001)The PHQ-9: A New Depression Diagnostic and Severity Measure (2002)The validity of the Hospital Anxiety and Depression Scale (2002)Intraclass correlations: Uses in assessing rater reliability. (1979)Risk factors for suicide in psychiatric outpatients: A 20-year prospective study. (2000)Suicidality in Pediatric Patients Treated With Antidepressant Drugs (2006)Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents (2007)Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration (2009)Suicide Attempts and Nonsuicidal Self-Injury in the Treatment of Resistant Depression in Adolescents: Findings from the TORDIA Study (2011)The detection of psychiatric illness by questionnaire (1973)A scaled version of the General Health Questionnaire (1979)The Multidimensional Scale of Perceived Social Support (1988)The brief resilience scale: Assessing the ability to bounce back (2008)The MOS 36-Item Short-Form Health Survey (SF-36) (1993)Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)The importance of functional impairment to mental health outcomes: A case for reassessing our goals in depression treatment research (2009)Functional impairment in social anxiety disorder (2012)Evidence-Based Assessment of Obsessive–Compulsive Disorder (2016)Development and validation of the penn state worry questionnaire (1990)Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. (1998)Epidemiology of anxiety disorders in the 21st century (2015)Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. (2017)Relationship of subjective and objective social status with psychological and physiological functioning: Preliminary data in healthy, White women. (2000)SF-36 Health Survey Update (2000)An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4 (2009)
this work references cited by second hop

References

  • 1983The Hospital Anxiety and Depression Scale47,092 cited
  • 1992The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.33,714 cited
  • 1992The MOS 36-ltem Short-Form Health Survey (SF-36)30,026 cited
  • 1998The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-1019,139 cited
  • 1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
  • 1959THE ASSESSMENT OF ANXIETY STATES BY RATING11,442 cited
  • 2010Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )4,666 cited
  • 2007Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA’s Pediatric Suicidal Risk Analysis of Antidepressants1,023 cited
  • 2008Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale469 cited
  • 2007An effect-size analysis of pharmacologic treatments for generalized anxiety disorder179 cited
  • 2011Evidence-based pharmacological treatment of generalized anxiety disorder168 cited

Cited by

  • 2019Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis54 cited
  • 2013A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

50 cited
  • 2020Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials44 cited
  • 2019Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis39 cited